XBiotech XBIT
NASDAQ XBIT
$1.91 +0.04 (+2.14%)
At close: Nov 9, 2026 · 4:00 PM EST

XBiotech (XBIT) Long-Term Debt Issuances (2024 - 2025)

Updated

XBiotech's Long-Term Debt Issuances was -$250,000 in Q4 2025, compared with $250,000 a year earlier.

Analysis

XBiotech (XBIT) Long-Term Debt Issuances (2024 - 2025) Analysis & Trends

For FY2025, Long-Term Debt Issuances at XBiotech came in at -$10.25 million.

  • In earlier years, Long-Term Debt Issuances was $10.25 million in FY2024.
  • Quarterly Long-Term Debt Issuances has moved between -$10 million (Q1 2025) and $10 million (Q1 2024) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn -
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn -
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 9.98 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn -
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn -
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn -
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn -
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn -
10 XBiotech 58.23 Mn -439.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -250,000.00
Mar 31, 2025 -10.00 Mn
Dec 31, 2024 250,000.00
Mar 31, 2024 10.00 Mn
API Access

XBiotech Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=XBIT&period=max&api_key=YOUR_API_KEY